博腾股份涨2.02%，成交额2.03亿元，主力资金净流出52.23万元

Core Viewpoint - Boten Co., Ltd. has shown significant stock performance with a year-to-date increase of 66.27%, driven by its core business in CDMO services for pharmaceuticals [1][2]. Financial Performance - For the first half of 2025, Boten Co., Ltd. achieved a revenue of 1.621 billion yuan, representing a year-on-year growth of 19.88% [2]. - The net profit attributable to shareholders for the same period was 27.0595 million yuan, marking a substantial increase of 115.91% year-on-year [2]. Stock Market Activity - As of September 9, Boten's stock price reached 26.22 yuan per share, with a trading volume of 203 million yuan and a market capitalization of 14.302 billion yuan [1]. - The stock has experienced a recent upward trend, with a 5.39% increase over the last five trading days and a 61.35% increase over the last 60 days [1]. Shareholder Information - As of August 29, the number of shareholders for Boten Co., Ltd. was 52,700, a decrease of 0.75% from the previous period [2]. - The average number of circulating shares per shareholder increased by 0.75% to 9,502 shares [2]. Dividend Distribution - Since its A-share listing, Boten Co., Ltd. has distributed a total of 1.193 billion yuan in dividends, with 866 million yuan distributed over the past three years [3]. Institutional Holdings - As of June 30, 2025, Hong Kong Central Clearing Limited was the fifth-largest circulating shareholder, increasing its holdings by 2.3886 million shares to 10.7589 million shares [3]. - New institutional investors include Southern CSI 1000 ETF, which holds 3.0218 million shares [3].